Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients
2011

Safety of H1N1 Vaccine in Egg Allergic Patients

Sample size: 59 publication Evidence: moderate

Author Information

Author(s): Pitt Tracy, Kalicinsky Chrystyna, Warrington Richard, Cisneros Nestor

Primary Institution: Health Sciences Centre, Winnipeg, Manitoba, Canada

Hypothesis

Is it safe to administer the H1N1 vaccine to patients with egg allergies?

Conclusion

The H1N1 vaccine is safe to administer to individuals with egg allergies, with only one patient showing a positive skin test.

Supporting Evidence

  • Out of 59 patients, only 1 (1.7%) had a positive skin test to the H1N1 vaccine.
  • All patients with negative skin tests tolerated the vaccine without adverse events.
  • The study supports the CSACI guidelines for administering the vaccine to egg allergic patients.

Takeaway

Most people with egg allergies can safely get the H1N1 vaccine without any problems.

Methodology

Patients were skin tested for the H1N1 vaccine and those with negative tests were vaccinated and observed for 30 minutes.

Limitations

The study had a small sample size and only included patients with a history of egg allergy.

Participant Demographics

Participants ranged from 1 to 27 years old, with a mean age of 5.6 years; 69.5% were male.

Statistical Information

Confidence Interval

90.23%, 99.67%

Digital Object Identifier (DOI)

10.1186/1710-1492-7-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication